MDMA and citalopram + Placebo
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
15
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
MDMA Mechanism of Action
Conditions
MDMA Mechanism of Action
Trial Timeline
Feb 1, 2009 → Aug 1, 2011
NCT ID
NCT00838305About MDMA and citalopram + Placebo
MDMA and citalopram + Placebo is a pre-clinical stage product being developed by Pacific Biosciences for MDMA Mechanism of Action. The current trial status is completed. This product is registered under clinical trial identifier NCT00838305. Target conditions include MDMA Mechanism of Action.
Hype Score Breakdown
Clinical
5
Activity
2
Company
2
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00838305 | Pre-clinical | Completed |
Competing Products
1 competing product in MDMA Mechanism of Action
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| 3,4-methylenedioxymethamphetamine or Placebo | Pacific Biosciences | Pre-clinical | 15 |